Study to Evaluate the Pharmacokinetics of a New Tablet Formulation of CPI-444 in Fed and Fasted Healthy Male and Female Subjects
Clinical trial NCT03237988 · COMPLETED
Trial details
- NCT number
- NCT03237988
- Sponsor
- Corvus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-20
- Primary completion
- 2017-09-20
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.